Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05191485

Shared Decision Making in Patients With Lung Cancer

Shared Decision Making in Patients With Lung Cancer After Surgery:a Molecular Testing Decision Aid Evidence Based Development Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
190 (estimated)
Sponsor
Sichuan Cancer Hospital and Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to develop a Decision Aid for Lung Cancer Molecular Testing (DA\_LCMT) and to facilitate shared-decision making in patients who were diagnosed with lung adenocarcinoma by intraoperative frozen pathology about whether to conduct the molecular testing.

Detailed description

Under the guidance by Ottawa Decision Support Framework (ODSF), International Patient Decision Aid Standards (IPDAS) and FDA guidance for Identify what is important to patients, the investigators use semi-structured interviews qualitative research methods to generate the decision making needs items of lung cancer patients who were diagnosed with lung adenocarcinoma by intraoperative frozen section pathology and other stakeholders (including thoracic surgeons, nurses, hospital administrators, molecular testing company staffs and insurance company staffs). Then modified Delphi will be used to develop the Decision Aid for Lung Cancer Molecular Testing version 1.0 (DA\_LCMT 1.0). One-to-one structured interviews qualitative research methods will be used in the Cognitive debriefing (alpha tests) and Field testing (β tests) to revise and improve the DA\_LCMT from version 1.0 to finally version 3.0. Descriptive statistics will be used to summarize the baseline characteristics of patients and other stakeholders. Qualitative data will be analyzed by the three steps proposed by grounded theory.

Conditions

Interventions

TypeNameDescription
OTHERQualitative interviewsWe will conduct semi-structured interviews with target patients, patients' representatives and other stakeholders to assess their decisional needs. The cognitive debriefing interview will start afterwards, and participants will answer probing questions asked by interviewers about DA\_LCMT 1.0. Then the field testing interviews will conducted one-on-one structured interviews.

Timeline

Start date
2023-02-22
Primary completion
2025-12-31
Completion
2026-12-01
First posted
2022-01-13
Last updated
2025-06-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05191485. Inclusion in this directory is not an endorsement.